Repligen (RGEN) - Cash on Hand

Cash on Hand as of June 2026 : £0.61 Billion

According to Repligen 's latest financial reports the company has £0.61 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Repligen - Cash on Hand chart (from 1996 to 2026)

Cash on Hand by year

Year	Cash on Hand	Change
2025-12-31	£0.56 B	-5.55%
2024-12-31	£0.60 B	2.34%
2023-12-31	£0.58 B	14.38%
2022-12-31	£0.51 B	15.26%
2021-12-31	£0.44 B	-15%
2020-12-31	£0.52 B	30.59%
2019-12-31	£0.40 B	163.9%
2018-12-31	£0.15 B	18.77%
2017-12-31	£0.12 B	11.89%
2016-12-31	£0.11 B	137.24%
2015-12-31	£48.43 M	29%
2014-12-31	£37.54 M	0.5%
2013-12-31	£37.35 M	50.75%
2012-12-31	£24.78 M
2011-03-31	£30.94 M	-10.93%
2010-03-31	£34.74 M	2.84%
2009-03-31	£33.78 M	36.33%
2008-03-31	£24.78 M	114.96%
2007-03-31	£11.52 M	5.56%
2006-03-31	£10.92 M	19.57%
2005-03-31	£9.13 M	21.52%
2004-03-31	£7.51 M	-23.68%
2003-03-31	£9.84 M	-32.65%
2002-03-31	£14.62 M	-13.56%
2001-03-31	£16.91 M	-20.79%
2000-03-31	£21.35 M	944.99%
1999-03-31	£2.04 M	-27.1%
1998-03-31	£2.8 M	31.75%
1997-03-31	£2.12 M	-52.99%
1996-03-31	£4.52 M

Cash on Hand for similar companies or competitors

Company	Cash on Hand	differencediff.	Country
Pfizer PFE	£8.84 B	1,343.40%	🇺🇸 USA
Thermo Fisher Scientific TMO	£3.07 B	401.45%	🇺🇸 USA
General Electric GE	£7.06 B	1,053.06%	🇺🇸 USA
Bristol-Myers Squibb BMY	£8.36 B	1,265.54%	🇺🇸 USA
Sangamo Therapeutics SGMO	£20.85 M	-96.60%	🇺🇸 USA
Novavax NVAX	£0.54 B	-11.24%	🇺🇸 USA
Neurocrine Biosciences NBIX	£0.29 B	-51.90%	🇺🇸 USA
Bio-Techne TECH	£0.20 B	-67.34%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	£0.66 B	7.84%	🇺🇸 USA
Charles River Laboratories CRL	£0.14 B	-76.31%	🇺🇸 USA

Repligen (RGEN) - Cash on Hand

Cash on Hand as of June 2026 : £0.61 Billion

Repligen - Cash on Hand chart (from 1996 to 2026)

Cash on Hand by year

Cash on Hand for similar companies or competitors

What is the market capitalization of a company?

DISCLAIMER

Contact

Links